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Abstract
Objectives: Endothelial injury during harvest influences graft patency post CABG. We have previously shown that
endoscopic harvest causes structural and functional damage to the saphenous vein (SV) endothelium. However,
causes of such injury may depend on the extraction technique. In order to assess this supposition, we evaluated
the effect of VirtuoSaph endoscopic SV harvesting technique (VsEVH) on structural and functional viability of SV
endothelium using multiphoton imaging, biochemical and immunofluorescence assays.
Methods: Nineteen patients scheduled for CABG were prospectively identified. Each underwent VsEVH for one
portion and “No-touch” open SV harvesting (OSVH) for another portion of the SV. A two cm segment from each
portion was immersed in GALA conduit preservation solution and transported overnight to our lab for processing.
The segments were labeled with fluorescent markers to quantify cell viability, calcium mobilization and generation
of nitric oxide. Morphology, expression, localization and stability of endothelial caveolin, eNOS, von Willebrand
factor and cadherin were evaluated using immunofluorescence, Western blot and multiphoton microscopy (MPM).
Results: Morphological, biochemical and immunofluorescence parameters of viability, structure and function were
well preserved in VsEVH group as in OSVH group. However, tonic eNOS activity, agonist-dependent calcium
mobilization and nitric oxide production were partially attenuated in the VsEVH group.
Conclusions: This study indicates that VirtuoSaph endoscopic SV harvesting technique preserves the structural and
functional viability of SV endothelium, but may differentially attenuate the vasomotor function of the saphenous
vein graft.
Ultramini-Abstract: Endoscopic extraction preserved the structure and function, but attenuated the calcium
mobilization and nitric oxide generation in human SV endothelium.
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Introduction
T h eS a p h e n o u sV e i n( S V )i st h em o s tc o m m o n l yu s e d
autologous homograft in patients undergoing coronary
artery bypass grafting (CABG) surgery. Preserving viable
endothelium of SV grafts harvested during coronary
revascularization impacts the grafts patency rate [1-11].
The integrity of the endothelial lining is affected by many
factors during harvest. Using epifluorescence multipho-
ton imaging techniques, we have previously shown that
the pH, temperature, SV distention, and composition of
storage solution can affect the endothelial viability and
function [4,12-15]. Similarly, surgical manipulation can
also damage the endothelium of SV grafts, increasing the
risk of vasospasm, thrombogenesis, occlusive intimal
hyperplasia, and stenosis [4,5,10,11].
Saphenous vein has traditionally been harvested using
an open surgical technique with minimal manipulation of
the vein [16]. However, many centers have adapted to the
minimally invasive surgical technique of endoscopic
saphenous vein harvest (EVH) because of patient prefer-
ence and decreased incidence of, lower extremity morbid-
ity, related to cellulitis and wound infection, hematoma,
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compared to the open technique [17-25]. The recently
published secondary analysis of PREVENT-4 study com-
pared outcomes after on-pump vs off-pump CABGs and
reported SV graft occlusion rates of 46.7% at 12-18
months, far in excess of historical assumptions by cardio-
vascular surgeons. More concerning, they found EVH to
be an independent predictor of decreased SV graft patency
at one year, the cause of which was not defined, warrant-
ing further investigations [26]. Likewise, a recently com-
pleted randomized on/off bypass (ROOBY) trial has
concluded that EVH was associated with lower SV graft
patency at 1-year and higher rate of perioperative myocar-
dial infarction and need for revascularization within 1-year
compared to OSVH [27]. Although both the PREVENT
IV and ROOBY studies were not randomized with regard
to the SV harvest technique, their findings are of great
concern due to the large number of cases that were
evaluated.
Although the EVH procedures utilizing the currently
available technology follow a similar minimally invasive
technique, differences still exist due to the unique proper-
ties of different devices as well as the experience of surgi-
cal operator. This study design evaluates viability of veins
harvested by the VirtuoSaph endoscopic vein harvesting
technique and OSVH methodology. The OSVH consisted
of removing the saphenous vein with perivascular tissue in
the traditional open fashion with “No-touch” technique.
We compared the viability and functionality of SV
endothelium between VsEVH, and OSVH as an internal
control, using three independent techniques: 1) epifluores-
cence multiphoton microscopy (MPM); 2) immunofluor-
escence and; 3) biochemical assays.
Materials and methods
Study Design and Experimental Protocol
This study was designed to be consistent with our earlier
study [28]. Patients, ages 56 - 82, (average 69.3 years),
scheduled for elective coronary artery bypass surgery at
the Saint Joseph’s Hospital of Atlanta, were prospectively
identified for the evaluation of VirtuoSaph endoscopic
harvest instrumentation and technique. The vein samples
were collected according to the protocol approved by the
Human Studies Subcommittee, and after obtaining
informed consent from the patients. Each patient under-
went VsEVH for the proximal portion of the vein and
OSVH for the distal portion of the vein. Endoscopic inci-
sion was located just below the knee, with “No touch”
incision in the upper calf; samples were taken to include
side branches in every instance. At no time was the vein
insufflated with any solution, and the “experimental”
endoscopic sample was obtained from the midportion of
the thigh segment after exteriorization to accommodate
prioritized patient requirements for a suitable bypass
conduit. For the VsEVH portion, minimal CO2 insuffla-
tion using an open system was used for visualization and
dissection of the tissues around the vein. Once the vein
was mobilized, the side branches were simultaneously cut
and cauterized with the bipolar V-cutter/cautery. The
distance between the two sampling areas was (26.58 ±
3.84 cm).
Harvesting techniques were performed by two experi-
enced physician’s assistants with over 7 years EVH
experience, and greater than 2000 cases performed,
respectively. VsEVH was conducted according to Ter-
umo guidelines and training, utilizing the VirtuoSaph
Endoscopic Vein Harvesting System (MCVS550, Ter-
umo Cardiovascular Systems Corp., Ann Arbor, Michi-
gan). A two centimeter portions of the VsEVH and
OSVH vein were immersed in ice cold GALA, and
transported overnight in a CoolPack by FedEx, from
Atlanta to our laboratory in VABHS, Boston, MA. Tran-
sit time and temperature (20 ± 2.2 hours; 7 ± 2.3°C;
respectively) were recorded in the laboratory.
Structural and Functional Assays
Cell Viability Assay
Structural and functional viability of saphenous vein
endothelial and smooth muscle cells were assessed with
a fluorescence-based Live-Dead (calcein AM/ethidium
homodimer) assay and MPM as described
[4,12-14,28,29]. The SV segments were incubated with
calcein AM and ethidium homodimer dyes (10 μM, final
concentration) in 1.5 ml of Hanks balanced salt solution
(HBSS), pH 7.4, for 30 minutes at 21°C. After incuba-
tion, segments were washed three times with HBSS,
mounted on the multiphoton microscope stage in an
imaging chamber, and viable cells (green fluorescence)
and damaged cells (red fluorescence) were imaged as
described below.
Measurement of Esterase Activity
The conversion of calcein AM ester (nonfluorescent)
to green fluorescent calcein by the esterases in living
cells was used as a marker of esterase activity in the
endothelial cells of the vein segments. Saphenous vein
lumen and endothelial cell layer were identified by
XYZ scanning using MPM. Specifically, five different
regions of uniform size were marked on the endothe-
lial cells in the lumen of each segment using image
processing software (MetaMorph Imaging Series; Uni-
versal Imaging, Corp., West Chester, PA). Total inte-
grated fluorescence intensity (photon counting) in the
marked regions of the endothelium was measured as a
function of esterase activity in the SV segments using
MetaMorph [4,12-14,28,29].
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Generation
Calcium mobilization and nitric oxide generation in
the endothelial cells of the SV was measured using cal-
cium sensitive calcium orange dye and nitric oxide
specific diaminofluorescein (DAF) dye, as previously
described [4,12-14,28,29]. Resting calcium levels and
basal/tonic activity of eNOS were measured in the
absence of bradykinin stimulation. The segments were
imaged using MPM, and bradykinin stimulated calcium
mobilization and nitric oxide generation were assessed
in real time over the course of 10 minutes and quanti-
fied as described below.
Quantitative Analysis of Calcium and Nitric Oxide
Calcium mobilization and nitric oxide generation were
measured by recording changes in calcium orange and
DAF fluorescence using MPM imaging, before and after
bradykinin treatment as described [4,12-14,28,29]. Typi-
cally, five specific regions were drawn along the
endothelial region of the lumen for each vein segment
using MetaMorph image processing software. Fluores-
cence intensity was integrated over all pixels within the
boundary of each individually enclosed area and the
quantum yield was measured in calcium and nitric
oxide fluorescence channels, respectively. The fluores-
cence intensity from each image was normalized by
values determined from a reference image recorded
before bradykinin treatment [4,12-14,28,29].
Immunofluorescence
Vein frozen sections were labeled with primary caveolin 1,
eNOS, Cadherin and von Willebrand factor (vWF) antibo-
dies as described [28,29]. After primary antibody labeling,
sections were washed 3X with PBS and labeled with either
fluorescein and/or texas red conjugated secondary antibo-
dies (1:200 dilution) in PBS for 2 hours at 21°C. Labeled
samples were washed 3X with PBS, mounted and imaged
using MPM.
Multiphoton Microscopy
Imaging and fluorescence measurements in all samples
were performed with a Zeiss LSM 710 Confocal-Mai-
Tai multiphoton imaging system (Carl Zeiss Microi-
maging, Inc., Thornwood, NY; Spectra-Physics,
Mountain View, CA) as described previously [4,
12-14,28,29] in transmission and epifluorescence
mode. The 512 × 512 pixel images were collected in
direct detection configuration at a pixel resolution of
0.484 μm. The endothelial cell layers were identified
by XYZ scanning and imaged at depths of 50 μm
away from the site of excision in transverse sections of
the SV segments.
Western Blotting
Protein extraction and electrophoresis were performed
as described [28,29]. All SV samples were processed at
4°C. Twenty milligrams of SV was cut into 300 small
pieces and suspended in 200 ml of CelLytic MT Lysis/
Extraction buffer (Sigma) containing a protease inhibitor
cocktail (Sigma). The tissue was homogenized, centri-
fuged and the protein concentration in the supernatant
was measured using the Bio-Rad protein assay. Equal
amount of total proteins (50 mg) were resolved on 7.5%,
10% or 12% SDS-PAGE, and electro-blotted onto the
nitrocellulose membrane (BioRad). Blots were incubated
with anti- caveolin 1, eNOS, cadherin, and vWF antibo-
dies (1:1000) and were subsequently incubated with
horseradish peroxidase conjugated secondary antibodies
(1:8000; DAKO). Bound antibodies were detected using
ECL (Amersham Biosciences, Sweden). The blots were
imaged and analyzed using MetaMorph, [28,29].
Statistical Analyses
Different individuals in blinded fashion performed the
imaging, data extraction and analysis. Data are expressed
as mean ± standard deviation unless otherwise stated.
The differences between the two groups (OSVH and
VsEVH) were compared using Student’s t-test. Statistical
significance was accepted at the 95% confidence level
(P < 0.05). The data was derived from n = 475 measure-
ments for esterase activity, and from n = 95 for calcium
and nitric oxide assays, respectively, for each group
investigated. All analyses were performed using SAS sta-
tistical software (version 9.2, SAS Institution, Gary, NC)
The authors had full access to the data and take full
responsibility for its integrity. All authors have read and
agreed to the manuscript as written. The funding agen-
cies did not play any role in influencing data collection,
extraction and interpretation.
Results
Multiphoton imaging of SV samples in transmission
mode did not reveal any stretching, detachment or gross
breaks in endothelium and smooth muscle cells in both
g r o u p s ,F i g u r e1 aa n d1 b .S i m i l a r l y ,m o r p h o l o g i c a l
abnormalities were not observed in images of thin sec-
tions of SV samples in both groups, Figure 1c and 1d.
The endothelium remains firmly attached to the medial
region with no damage or breaks in the continuity of
the structure. Endothelial cells exhibited robust green
fluorescence, demonstrating structural integrity and via-
bility in both, OSVH and VsEVH samples, Figures 2a
and 2b. Additionally, vein samples in both groups did
not exhibit any membrane damage, either in the
endothelium or the smooth muscle cells, as indicated by
minimal red fluorescence, Figures 2c and 2d. Similarly,
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function of esterase activity, did not show any significant
difference (p < 0.2478) between OSVH and VsEVH
(186.83 +/- 49.82 vs 190.18 +/- 55.82, arbitrary units,
mean +/- SD, n = 475 measurements), respectively, indi-
cating similar endothelial cell viability.
Endothelial calcium and nitric oxide response in
absence (tonic/basal level) and presence (stimulatory/
functional response) of bradykinin are shown in Figure
3. Bradykinin stimulation resulted in increase in calcium
and nitric oxide fluorescence in both groups. However,
measurement of calcium mobilization and nitric oxide
production (quantum yields) in OSVH and VsEVH
group demonstrated a differential response. Bradykinin
stimulated calcium response was significantly greater in
OSVH than in VsEVH endothelium (p < 0.0124). Simi-
larly, in response to bradykinin stimulation of eNOS,
nitric oxide production in OSVH was greater than in
VsEVH group, but not significantly different (p < 0.321),
Figure 4.
Expression and localization of Caveolin, eNOS, vWF
and cadharin, components of endothelial cells involved
in cell signaling, structure and function, were similar in
both, OSVH and VsEVH groups, as demonstrated by
robust immunofluorescence in the endothelium of the
vein samples, Figure 5. Quantitative analysis of the
fluorescence did not show any significant difference
between the two groups.
Western blots of SV extracts did not demonstrate any
significant difference in the resolution of proteins between
O S V Ha n dV s E V Hg r o u p s ,F i g u r e6 ,c o n f i r m i n go u r
immunofluroescence observations, Figure 5. Even though,
intra variability in protein components between patients
was different, and is clearly visible on the Western blots,
Figure 1 Multiphoton images of SV in the transmission mode.
Endothelium and smooth muscle cells do not show visible damage
and remain intact in vessels harvested by both techniques. OSVH:
open saphenous vein harvest; VsEVH: VirtuoSaph endoscopic
harvest. Magnification 400X Figure 1a. Intact saphenous vein Figure
1b. Frozen sections: 40 μ m
Figure 2 Esterase activity in the OSVH and VsEVH samples: Representative images showing similar esterase activity and viability (green
fluorescence) in both samples (a and b). Both techniques caused minimal visible damage to the vessels as indicated by attenuated red
fluorescence in endothelial and smooth vessel regions (c and d). Magnification = 400 ×.
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post bradykinin stimulation in the OSVH and VsEVH groups. (B) Representative images of nitric oxide production pre and post bradykinin
stimulation. Magnification = 400 x.
Figure 4 Quantitative representation of normalized calcium mobilization and nitric oxide production in the OSVH and VsEVH groups.
Bradykinin induced calcium mobilization and nitric oxide production was greater in the OSVH group over baseline than in the VsEVH group. N
= 95 measurements for each group.
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patient sample was very similar, Figure 6. Therefore, aver-
aged values of densitometer scans of proteins in OSVH
samples were not different than those in the VsEVH
group within the patient sample.
The measurable changes observed in structural and
functional proteins between the two harvesting techni-
ques as measured by the three different assaying techni-
ques are summarized in Table 1.
Discussion
Despite the widespread acceptance that arterial grafts
are superior to venous conduits in coronary revascular-
ization procedures, the desire to achieve complete
revascularization and the relative ease of use of SV
conduits has ensured their continued widespread
usage. Most cardiovascular surgeons are well aware of
the necessity to avoid over distension of the SV con-
duit during harvest and subsequent preparation, in
preventing mechanical disruption of the endothelium.
Despite our earlier communication that endovascular
harvest techniques resulted in profound intimal injury
relative to classic open harvest “No-touch” techniques
[28], patient demand for improved cosmesis and
quicker functional recovery has superseded concerns
regarding endothelial integrity. Indeed, the mounting
evidence that endoscopic saphenous vein harvest can
reduce lower extremity morbidity, has led many sur-
geons to adopt this technique [20-26]. However, the
endoscopic technique may result in increased mechani-
cal traction on the vein, promotes possible thermal
injury by the use of cautery to control side branches,
and result in excessive exposure to an acidotic envir-
onment from high CO2 pressure, which may result in
impaired endothelial function of the venous conduits.
Therefore, development of both, adequate instrumenta-
tion and reproducible technique of endoscopic harvest
Figure 5 Immunofluorescent labeling of endothelial cell markers in SV samples. Representative fluorescence images showing normal
distribution of caveolin, eNOS, von Willebrand factor and cadherin in both, OSVH and VsEVH groups. Harvesting of SV using the VirtuoSaph
endoscopic technique did not damage or alter the localization of proteins in the endothelium. Magnification = 400 x.
Figure 6 Western blot analysis of SV harvested by OSVH and
VsEVH technique demonstrates similar resolution and
concentration of endothelial proteins. Endoscopic harvesting
using VirtuoSaph did not negatively affect the endothelial proteins
in SV samples. Samples 1-6: OSVH Group; Corresponding samples 7-
12: VsEVH Group.
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We hope to continue to address these issues at the
basic level, with our previous [28], current, and
ongoing studies, to be able to provide informed
choices for the cardiac surgeons in deciding open or
endoscopic harvesting for improved conduit quality
and long-term outcomes for the patients.
In this investigation, as the SVs from harvest to analy-
sis involved substantial transit time, and cold, albeit,
potentially variable temperature exposure, it was of pri-
mary concern to us that the vessels remain fully viable
during this period. We havep r e v i o u s l ys h o w nt h a t
GALA surgical conduit preservation solution, used in
our hospital for CABG and peripheral vascular surgery,
maintains the structural and functional viability of the
blood vessel endothelium during short- and long-term
(over 24 hour) storage [14]. This coupled with excellent
graft patency, and long-term outcomes in over 3000
patients treated with GALA in our VA hospital con-
vinced us that GALA would be an ideal solution for pre-
servation and transport of the SV samples to our
laboratory. That, GALA indeed preserves the morpholo-
gical and physiological viability of SV conduits during
transit, was reconfirmed by the fact that the vein sam-
ples remained structurally and functionally intact, with
no visible morphological change, membrane damage or
loss of proteins, and with robust calcium mobility,
eNOS activity and NO generation, Figures 1-6. Mea-
sured values of these samples were within the range for
those of freshly harvested and analyzed SVs as reported
by us [4,12-14,28,29].
We have previously shown that the endothelium is sub-
stantially damaged during harvesting of SV using an
endoscopic technique [28]. The parameters of endothelial
structure and function were altered significantly in the
endoscopic samples, including the impairment of esterase
activity, calcium mobilization and nitric oxide generation.
Additionally, extensive stretching and disruption of
membrane proteins, demonstrating damage to the
endothelium and the smooth muscle cells were also
observed [28]. In contrast, in this study, harvesting of the
SV using the VirtuoSaph did not reveal any structural
and functional cellular damage. Morphological structure,
esterase activity and endothelial viability were well main-
tained in the endoscopic samples (VsEVH), similar to
those observed in the corresponding samples harvested
by the “No touch” open technique (OSVH), Figures 1-4.
These findings were also confirmed by using two
other independent assessment techniques. Immunofluor-
escence labeling of vessel samples demonstrated that
expression, localization and distribution of caveolin,
eNOS, vWF and cadharin were well preserved in
VsEVH endothelium similar to those in OSVH samples,
Figure 5. Equally, Western blot analysis demonstrated
that the endothelial proteins were well conserved in
samples from both groups, Figure 6. These results
clearly demonstrate that unlike our previous observation
[28], endoscopic harvesting of SV using VituoSaph does
not cause structural damage to the endothelium and the
smooth muscle.
Even though we did not observe any visible and mea-
sureable changes in caveolin and eNOS in the endothe-
lium of VsEVH samples, the calcium mobilization and
nitric oxide production appeared to be differentially
altered. As shown in Figures 3 and 4, Bradykinin stimu-
lated mobilization of calcium and eNOS mediated nitric
oxide generation was deceased in VsEVH samples in
comparison to the OSVH samples, indicating attenua-
tion of endothelial function, confirming our earlier
observation [28]. Preservation of bypass conduit eNOS
activity and nitric oxide generation has important impli-
cations on immediate graft function, long-term patency
and patient outcomes. Because nitric oxide induces
vasodilation, inhibits platelet and neutrophil adhesion
and prevents atherosclerosis, the impaired ability of the
endoscopically harvested SV endothelium to produce
nitric oxide, may lead to attenuated vasomotor function
with significant implications on graft patency and
patient outcomes. It is not clear, however, that the
impairment we observed in the endothelial response is
permanent or of clinical significance. It is possible that
this defect may reverse with time, especially as VsEVH
samples do not demonstrate any membrane damage and
Table 1 Summary of Results





Calcium Mobilization after BK stimulation ↑











SMC = smooth muscle cells; BK = bradykinin; NO = Nitric Oxide; eNOS =
Endothelial Nitric Oxide Synthase; vWF = Von Weillebrand Factor
Hussaini et al. Journal of Cardiothoracic Surgery 2011, 6:82
http://www.cardiothoracicsurgery.org/content/6/1/82
Page 7 of 9alteration in the functional protein components, Figures
5 and 6, unlike our previous observations [28].
Multiphoton imaging in the transmission mode did
not demonstrate any endothelial disruption in the
VsEVH samples, Figure 1. Even though this observation
may contradict our functional (calcium/nitric oxide)
assays, it is not imperative to observe disrupted
endothelium to observe attenuated function. Perhaps
some stretching and/or manipulation of the vessel
inherent in VsEVH technique were sufficient to tem-
porarily impair endothelium function. There is also the
possibility that cautery thermal effects and CO2 insuffla-
tion used in VsEVH techniques, though minimal with
VirtuoSaph, could potentially be harmful to the vein
and may be responsible for our observations. We are
currently in the process of evaluating the effects of CO2
on vein structure and function to eliminate one
possibility.
Conclusion
The principal findings of this investigation is that unlike
in our previous endoscopic harvesting study [28], extrac-
tion of the SV using the VirtuoSaph lends to preserva-
tion of morphological structure and biochemical
function in the conduit. These results imply that it is
not the EVH technique per se that causes conduit
damage and eventual graft failures [26,27] but other per-
tinent factors may contribute to this problem. However,
comparative studies are required to examine not only
graft patency rates at one year postoperatively, but also
patient outcomes with respect to the technique used to
harvest the SV conduits. Irrespective of method of endo-
scopic harvest used, proper instrumentation, procedural
training and technical expertise of the personnel
involved in the process is of crucial importance to pre-
serve the saphenous vein as a truly viable bypass
conduit.
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